Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Cescon

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Scientific Reports|November 10, 2018
The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) AntagonismMitchell J Elliott, Katarzyna J Jerzak, Jessica G Cockburn, et al.
Therapeutic Advances in Medical Oncology|April 29, 2025
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancerPeter Schmid, Mafalda Oliveira, Joyce O'Shaughnessy, et al.
International Journal of Molecular Sciences|May 13, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed AssayScott Strum, Clodagh Murray, Sofia Genta, et al.
Gynecologic Oncology|September 11, 2020
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancerAinhoa Madariaga, Swati Garg, Jeffrey P Bruce, et al.
Cancers|October 29, 2025
Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast CancerVasudeva Bhat, Kelsie L Thu, Anayra de Fatima Goncalves Santiago, et al.
International Journal of Molecular Sciences|March 28, 2026
Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast CancerKelsie L Thu, Soode Jafari, Jennifer Silvester, et al.
Cancer Research|June 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast CancerSasha C Main, Mitchell J Elliott, Althaf Singhawansa, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 20, 2019
Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid CultureAlexander E G Baker, Laura C Bahlmann, Roger Y Tam, et al.
Nature Communications|October 25, 2022
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statinsJenna E van Leeuwen, Wail Ba-Alawi, Emily Branchard, et al.
Nature Communications|March 19, 2022
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoidsElisabeth Prince, Jennifer Cruickshank, Wail Ba-Alawi, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Scientific Reports|November 10, 2018
The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) AntagonismMitchell J Elliott, Katarzyna J Jerzak, Jessica G Cockburn, et al.
Therapeutic Advances in Medical Oncology|April 29, 2025
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancerPeter Schmid, Mafalda Oliveira, Joyce O'Shaughnessy, et al.
International Journal of Molecular Sciences|May 13, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed AssayScott Strum, Clodagh Murray, Sofia Genta, et al.
Gynecologic Oncology|September 11, 2020
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancerAinhoa Madariaga, Swati Garg, Jeffrey P Bruce, et al.
Cancers|October 29, 2025
Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast CancerVasudeva Bhat, Kelsie L Thu, Anayra de Fatima Goncalves Santiago, et al.
International Journal of Molecular Sciences|March 28, 2026
Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast CancerKelsie L Thu, Soode Jafari, Jennifer Silvester, et al.
Cancer Research|June 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast CancerSasha C Main, Mitchell J Elliott, Althaf Singhawansa, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 20, 2019
Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid CultureAlexander E G Baker, Laura C Bahlmann, Roger Y Tam, et al.
Nature Communications|October 25, 2022
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statinsJenna E van Leeuwen, Wail Ba-Alawi, Emily Branchard, et al.
Nature Communications|March 19, 2022
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoidsElisabeth Prince, Jennifer Cruickshank, Wail Ba-Alawi, et al.
Pageof 14